Systematic Financial Management LP Gsk PLC Transaction History

Systematic Financial Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $840,714 - $967,476	-22,200 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$32.47 - $48.83 $133,127 - $200,203	-4,100 Reduced 15.59%	22,200 $841,000
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $470,400 - $540,400	-11,200 Reduced 29.87%	26,300 $1.24 Million
Q3 2019 Nov 06, 2019	BUY	$40.46 - $43.52 $740,418 - $796,416	18,300 Added 95.31%	37,500 $1.6 Million
Q2 2019 Jul 26, 2019	SELL	$39.4 - $42.7 $51,220 - $55,510	-1,300 Reduced 6.34%	19,200 $768,000
Q3 2018 Nov 06, 2018	BUY	$39.75 - $42.69 $814,875 - $875,145	20,500 New	20,500 $823,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.